Treatment of redness in rosacea with potassium-titanyl-phosphate (KTP) 532 nm laser with and without topical 1% ivermectin cream: a randomized split-face trial.

Key Points

• The aim is to evaluate the effectiveness of KTP laser treatment in reducing redness associated with rosacea, both with and without topical ivermectin.
• Conducted a randomized split-face trial
• Participants received KTP laser treatment on one side of the face and a placebo or topical ivermectin on the other
• Assessed skin redness levels post-treatment
• KTP laser treatment significantly reduced skin redness compared to baseline
• Combination with topical ivermectin showed further improvement in redness reduction
• Findings were statistically significant, indicating a beneficial effect of both interventions